Ronald W. Davis, PhD, Director
Dr. Davis’ history of interdisciplinary work, technology development, and attacking previously unsolvable biological problems (both in genetics and traumatology) makes him the ideal scientist to lead
sponsored by Open Medicine Foundation (OMF)
A unique and up-close opportunity to learn from and interact with world-class scientists.
The Third Annual Community Symposium on the Molecular Basis of ME/CFS, sponsored by OMF, took place on September 7, 2019 at Stanford University. It brought together hundreds of researchers, clinicians, patients, caregivers, families, and advocates, and thousands more by livestream.
Opening Remarks:
Ronald W. Davis, PhD
Welcome: Linda Tannenbaum and Chris Armstrong
Greetings
Janet Dafoe, PhD, Patient Liaison
Symposium Logistics
Ashley Haugen, Event Organizer
Raeka Aiyar, PhD, Revolutionizing Disease Research with Stem Cells
Robert Harrington, MD: Video from the Stanford Chair of Medicine
Maureen Hanson, PhD | Keynote Address
Thoughts and Data about ME/CFS
Alain Moreau, PhD
Let’s Talk About You and ME
Oystein Fluge, MD, PhD
Lessons from clinical trials in ME/CFS
Q&A Panel Discussion
Morning Speakers
Ron Tompkins, MD, ScD | OMF ME/CFS
Collaboration at Harvard
Jonas Bergquist, MD, PhD
A short video update
Juan Santiago, PhD | Quantification of RBC Deformability
Mike Snyder, PhD
Big Data, Wearables, and Health
Robert Phair, PhD
Metabolic Traps in ME/CFS
Ronald W. Davis, PhD
What’s Next?
Q&A Panel Discussion
Afternoon Speakers
Closing Remarks
Ronald W. Davis
The Symposium is preceded by a 3-day Science Meeting of our international working group.
Saturday, September 7, 2019 at Paul Brest Hall, Stanford University
08:00 a.m. Registration
09:00 a.m. Opening Remarks: Ronald W. Davis, PhD, Stanford University
09:10 a.m. Welcome: Linda Tannenbaum, CEO, OMF
09:15 a.m. Introduction to OMF Liason: Chris Armstrong, PhD
09:20 a.m. Greetings: Janet Dafoe, PhD, Patient Liaison
09:25 a.m. Symposium Logistics: Ashley Haugen, Event Organizer
09:30 a.m. Raeka Aiyar, PhD, Symposium Moderator, New York Stem Cell Foundation Research Institute
Revolutionizing disease research with stem cells
09:45 a.m. Robert Harrington, MD, Video from the Stanford Chair of Medicine
10:00 a.m. Keynote Address: Maureen Hanson, PhD, Cornell University
Thoughts and Data about ME/CFS
10:30 a.m. BREAK
10:50 a.m. Alain Moreau, PhD, University of Montreal
Let’s Talk About You and ME: An exploration of recent progresses to decode Myalgic Encephalomyelitis
11:15 a.m. Oystein Fluge, MD, PhD, University of Bergen
Lessons from clinical trials in ME/CFS
11:40 a.m. Panel Discussion: Morning Speakers
12:10 p.m. LUNCH
01:15 p.m. Ron Tompkins, MD, ScD, Harvard University
OMF ME/CFS Collaboration at the Harvard Affiliated Hospitals
01:40 p.m. Jonas Bergquist, MD, PhD, (Video), Uppsala University
A short update of the research activities at the ME/CFS Collaborative Research Centre in Uppsala
02:05 p.m. Juan Santiago, PhD, Stanford University
A study of red blood cell mechanics: Work towards a CFS diagnostic based on cell deformability
02:30 p.m. Mike Snyder, PhD, Stanford University
02:55 p.m. BREAK
03:15 p.m. Robert Phair, PhD, Integrative Bioinformatics Inc.
Metabolic Traps in ME/CFS
03:40 p.m. Ronald W. Davis, PhD, Stanford University
What’s Next?
04:05 p.m. Panel Discussion: Afternoon Speakers
Closing Remarks:
04:35 p.m. Ronald W. Davis, PhD
05:00 p.m. – 6:00 p.m. RECEPTION
Dr. Davis’ history of interdisciplinary work, technology development, and attacking previously unsolvable biological problems (both in genetics and traumatology) makes him the ideal scientist to lead
Dr. Robert Phair is an MIT electrical engineer who worked at the National Institutes of Health while in the US Public Health Service, earned a
Raeka Aiyar, PhD, is the Senior Director of Scientific Outreach at The New York Stem Cell Foundation Research Institute, and an experienced molecular biologist turned
Dr. Fluge has been courageous in pursuing his observations on the effects of rituximab on ME/CFS patients when that issue was not the planned focus of
Dr. Hanson has conducted groundbreaking molecular analysis of many facets of ME/CFS. She analyzes her data with sophistication and insight. It’s exciting to have such an
Juan Santiago received his MS and PhD in Mechanical Engineering from the University of Illinois at Urbana-Champaign in 1995. His research includes the development of
Dr. Bergquist is a Full Chair Professor in Analytical Chemistry and Neurochemistry in the Department of Chemistry at Uppsala University, Sweden, Adjunct Professor in Pathology
Sumner M. Redstone Professor of Surgery, Harvard Medical School Founding Director, Center for Surgery, Innovation & Bioengineering, Massachusetts General Hospital Former Co-Director, OMF-sponsored ME/CFS Collaboration at the
Dr. Alain Moreau is a Full Professor in the Faculty of Dentistry (Stomatology Department), cross-appointed to the Biochemistry and Molecular Medicine Department in the Faculty
Donate your appreciated stock directly to OMFCA and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).
OMFCA sells your securities and uses the proceeds to support our mission. You also do not pay capital gains tax on the transfer when the stock is sold. Giving appreciated stock can be more beneficial than giving cash. The “cost” of your gift is often less than the deduction you gain by making it. In advance, thank you for making this generous gift.
Gifting of Stock Instructions
Brokerage/Investment Firm: TD Waterhouse
Name on the Account: Open Medicine Foundation Canada
Account Number: 20LRHLA
OMFCA Canadian Revenue Agency (CRA) charity registration #: 74926 5518 RR0001
OMF Canada Registered Address:
Open Medicine Foundation Canada
2987 Baynes Road, Victoria, BC V8N-1Y4
Phone Number: 416-848-0055
Please speak to your personal tax advisor and then call OMFCA at 650-242-8669 to notify us of your donation or with any questions.